Louis Szeponik

6PUBLICATIONS
28CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 16, 2025
Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity.

Elena Garre, Sara Rhost, Anna Gustafsson

|May 14, 2022
Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer.

Donia Kaidi, Louis Szeponik, Ulf Yrlid

|Oct 23, 2021
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells.

Frank Liang, Azar Rezapour, Louis Szeponik

|Mar 19, 2020
Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice.

Louis Szeponik, Paulina Akeus, William Rodin

|Jan 23, 2019
Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells.

S Sharba, N Navabi, M Padra

|Dec 03, 2017
Migratory CD11b+ conventional dendritic cells induce T follicular helper cell-dependent antibody responses.

Jayendra Kumar Krishnaswamy, Uthaman Gowthaman, Biyan Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Ulf Yrlid

1 joint publications

S Sharba

1 joint publications

N Navabi

1 joint publications

J K Gustafsson